These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24551085)

  • 21. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
    Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
    Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
    Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ras responsive transcription factor RREB1 is a novel candidate gene for type 2 diabetes associated end-stage kidney disease.
    Bonomo JA; Guan M; Ng MC; Palmer ND; Hicks PJ; Keaton JM; Lea JP; Langefeld CD; Freedman BI; Bowden DW
    Hum Mol Genet; 2014 Dec; 23(24):6441-7. PubMed ID: 25027322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.
    Genovese G; Tonna SJ; Knob AU; Appel GB; Katz A; Bernhardy AJ; Needham AW; Lazarus R; Pollak MR
    Kidney Int; 2010 Oct; 78(7):698-704. PubMed ID: 20668430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.
    Colares VS; Titan SM; Pereira Ada C; Malafronte P; Cardena MM; Santos S; Santos PC; Fridman C; Barros RT; Woronik V
    PLoS One; 2014; 9(3):e87716. PubMed ID: 24658608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between
    Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
    J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.
    Lin CP; Adrianto I; Lessard CJ; Kelly JA; Kaufman KM; Guthridge JM; Freedman BI; Anaya JM; Alarcón-Riquelme ME; ; Pons-Estel BA; Martin J; Glenn S; Adler A; Bae SC; Park SY; Bang SY; Song YW; Boackle SA; Brown EE; Edberg JC; Alarcón GS; Petri MA; Criswell LA; Ramsey-Goldman R; Reveille JD; Vila LM; Gilkeson GS; Kamen DL; Ziegler J; Jacob CO; Rasmussen A; James JA; Kimberly RP; Merrill JT; Niewold TB; Scofield RH; Stevens AM; Tsao BP; Vyse TJ; Langefeld CD; Moser KL; Harley JB; Gaffney PM; Montgomery CG
    Genes Immun; 2012 Apr; 13(3):232-8. PubMed ID: 22189356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copy Number Variation at the APOL1 Locus.
    Ruchi R; Genovese G; Lee J; Charoonratana VT; Bernhardy AJ; Alper SL; Kopp JB; Thadhani R; Friedman DJ; Pollak MR
    PLoS One; 2015; 10(5):e0125410. PubMed ID: 25933006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
    Kopp JB; Winkler CA; Nelson GW
    Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
    Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
    Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
    Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.
    McDonough CW; Hicks PJ; Lu L; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2009 Aug; 126(2):265-75. PubMed ID: 19373489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
    Anderson BR; Howell DN; Soldano K; Garrett ME; Katsanis N; Telen MJ; Davis EE; Ashley-Koch AE
    PLoS Genet; 2015 Jul; 11(7):e1005349. PubMed ID: 26147622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
    Nelson GW; Freedman BI; Bowden DW; Langefeld CD; An P; Hicks PJ; Bostrom MA; Johnson RC; Kopp JB; Winkler CA
    Hum Mol Genet; 2010 May; 19(9):1805-15. PubMed ID: 20124285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Analysis of the Reticulon 1 Gene in End-Stage Kidney Disease.
    Bonomo JA; Palmer ND; He JC; Fan Y; Hicks PJ; Lea JP; Okusa MD; Bowden DW; Freedman BI
    Am J Nephrol; 2015; 42(4):259-64. PubMed ID: 26496126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.
    Rosset S; Tzur S; Behar DM; Wasser WG; Skorecki K
    Nat Rev Nephrol; 2011 Jun; 7(6):313-26. PubMed ID: 21537348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the genetic architecture of diabetic nephropathy.
    Palmer ND; Freedman BI
    Curr Diab Rep; 2012 Aug; 12(4):423-31. PubMed ID: 22573336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOL1 and nephropathy progression in populations of African ancestry.
    Freedman BI
    Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.